TY - JOUR T1 - The Power of Herbal Extracts and Essential Oils in the Fight Against Helicobacter pylori: A Current Review TT - Helicobacter pylori ile Mücadelede Bitki Özleri ve Uçucu Yağların Gücü: Güncel Bir İnceleme AU - Sipahi Kuloğlu, Selin AU - Kalefetoğlu Macar, Tuğçe AU - Macar, Oksal PY - 2025 DA - December Y2 - 2025 DO - 10.29002/asujse.1799861 JF - Aksaray University Journal of Science and Engineering JO - Aksaray J. Sci. Eng. PB - Aksaray University WT - DergiPark SN - 2587-1277 SP - 84 EP - 94 VL - 9 IS - 2 LA - en AB - Helicobacter pylori is a human pathogen bacterium that causes gastric and duodenal diseases. This bacterium, which infects approximately half of the global population, is classified as a Group I carcinogen. Diseases caused by this bacterium, which can lead to very serious conditions ranging from gastritis to stomach cancer, can develop due to iron deficiency anemia or B12 vitamin deficiency. The presence of this bacterium in the saliva, feces, and vomit of infected individuals indicates the possibility of transmission through these routes. Due to the emergence of antibiotic-resistant strains of H. pylori, there is a need for natural complementary treatments. The side effects of drugs have led researchers to turn to nature, and plant-based functional foods have gained importance. It is well recognized that active ingredients frequently present in plant extracts are crucial in the treatment of H. pylori. It is very valuable for literature to draw attention to these alternative treatments and make them available. KW - antibacterial activity KW - cancer KW - herbal oil KW - Helicobacter pylori N2 - Helicobacter pylori, mide ve oniki parmak bağırsağı hastalıklarına neden olan bir insan patojeni bakteridir. Küresel nüfusun yaklaşık yarısını enfekte eden bu bakteri, Grup I kanserojen olarak sınıflandırılmaktadır. Gastritten mide kanserine kadar çok ciddi durumlara yol açabilen bu bakterinin neden olduğu hastalıklar, demir eksikliği anemisi veya B12 vitamini eksikliği nedeniyle gelişebilir. Bu bakterinin enfekte bireylerin tükürüğünde, dışkısında ve kusmuğunda bulunması, bu yollardan bulaşma olasılığını gösterir. Antibiyotik dirençli H. pylori suşlarının ortaya çıkması nedeniyle, doğal tamamlayıcı tedavilere ihtiyaç vardır. İlaçların yan etkileri, araştırmacıları doğaya yöneltmiş ve bitki bazlı fonksiyonel gıdalar önem kazanmıştır. Bitki özlerinde sıklıkla bulunan aktif bileşenlerin H. pylori tedavisinde çok önemli olduğu iyi bilinmektedir. Literatürün bu alternatif tedavilere dikkat çekmesi ve bunları erişilebilir hale getirmesi çok değerlidir. CR - [1] Reshetnyak, V. I., Reshetnyak, T. M. (2017). Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J Gastroenterol, 23(27), 4867-4878. https://doi.org/10.3748/wjg.v23.i27.4867 CR - [2] Kusters, J. G., Van Vliet, A. H., & Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 19(3), 449-490. https://doi.org/10.1128/cmr.00054-05 CR - [3] Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R et al. (2023). Helicobacter pylori infection. Nat Rev Dis Primers. 9(1), 19. https://doi.org/10.1038/s41572-023-00431-8 CR - [4] Gürbüz, E. D., Yılmaz, Ö. (2011). Helicobacter pylori'nin Yaşam Stratejisi. Türk Mikrobiyoloji Cemiyeti Dergisi, 41(2), 49-56. https://doi.org/10.5222/TMCD.2011.049 CR - [5] Schreiber, S., Konradt, M., Groll, C., Scheid, P., Hanauer, G et al. (2004). The spatial orientation of Helicobacter pylori in the gastric mucus. PNAS. 101(14), 5024-5029. https://doi.org/10.1073/pnas.0308386101 CR - [6] Kirschner, D. E., Blaser, M. J. (1995). The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol. 176(2), 281-290. https://doi.org/10.1006/jtbi.1995.0198 CR - [7] Cover, T. L., Blanke, S. R. (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 3(4), 320-332. https://doi.org/10.1038/nrmicro1095 CR - [8] Sathianarayanan, S., Ammanath, A. V., Biswas, R., Sukumaran, S., Venkidasamy, B. (2022). A new approach against Helicobacter pylori using plants and its constituents: A review study. Microb Pathog. 168, 105594. https://doi.org/10.1016/j.micpath.2022.105594 CR - [9] Tabak, M., Armon, R., & Neeman, I. (1999). Cinnamon extracts’ inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 67(3), 269-277. https://doi.org/10.1016/S0378-8741(99)00054-9 CR - [10] Korona-Glowniak, I., Glowniak-Lipa, A., Ludwiczuk, A., Baj, T., & Malm, A. (2020). The in vitro activity of essential oils against Helicobacter pylori growth and urease activity. Molecules, 25(3), 586. https://doi.org/10.3390/molecules25030586 CR - [11] Cui, M., Ji, X., Guan, F., Su, G., & Du, L. (2024). Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics. Frontiers in immunology, 15, 1432968. https://doi.org/10.3389/fimmu.2024.1432968 CR - [12] Bordin, D. S., Voynovan, I. N., Andreev, D. N., Maev, I. V. (2021). Current Helicobacter pylori diagnostics. Diagnostics, 11(8), 1458. https://doi.org/10.3390/diagnostics11081458 CR - [13] Álvarez-Arellano, L., Maldonado-Bernal, C. (2014). Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 5(4), 400. https://doi.org/10.4291/wjgp.v5.i4.400 CR - [14] Sipponen, P. (1997). Helicobacter pylori gastritis—epidemiology. J Gastroenterol. 32(2), 273-277. https://doi.org/10.1007/BF02936382 CR - [15] Moss, S. F. (2017). The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 3(2), 183-191. https://doi.org/10.1016/j.jcmgh.2016.12.001 CR - [16] de Martel, C., Georges, D., Bray, F., Ferlay, J., Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2), e180-e190. https://doi.org/10.1016/S2214-109X(19)30488-7 CR - [17] Arnold, M., Moore, S. P., Hassler, S., Ellison-Loschmann, L., Forman, D et al. (2014). The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut, 63(1), 64-71. https://doi.org/10.1136/gutjnl-2013-305033 CR - [18] Gülseroğlu, S., Yılmaz, N., Tekin, D., Özamrak, B. G., Talu, E. C. K. (2023). Dışkı Örneklerinde Helicobacter pylori Antijen Testi Pozitifliği olan Hastaların Patoloji Bulguları ile Beraber Retrospektif Olarak Değerlendirilmesi. Ağrı Tıp Fakültesi Dergisi, 1(2), 26-29. https://dergipark.org.tr/tr/pub/agrimedical/article/1264062#article_cite CR - [19] Zamani, M., Ebrahimtabar, F., Zamani, V., Miller, W., Alizadeh‐Navaei, R et al. (2018). Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. AP&T. 47(7), 868-876. https://doi.org/10.1111/apt.14561 CR - [20] Liu, M., Gao, H., Miao, J., Zhang, Z., Zheng, L et al. (2024). Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review. Front Microbiol. 14, 1330029. https://doi.org/10.3389/fmicb.2023.1330029 CR - [21] Khoder, G., Muhammad, J. S., Mahmoud, I., Soliman, S. S., Burucoa, C. (2019). Prevalence of Helicobacter pylori and its associated factors among healthy asymptomatic residents in the United Arab Emirates. Pathogens, 8(2), 44. https://doi.org/10.3390/pathogens8020044 CR - [22] Stefano, K., Marco, M., Federica, G., Laura, B., Barbara, B et al. (2018). Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensis, 89(Suppl 8), 72. https://doi.org/10.23750/abm.v89i8-S.7947 CR - [23] Fock, K. M., Ang, T. L. (2010). Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 25(3), 479-486. https://doi.org/10.1111/j.1440-1746.2009.06188.x CR - [24] Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y et al. (2022). Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis. J Gastroenterol Hepatol. 37(3), 464-470. https://doi.org/10.1111/jgh.15751 CR - [25] Thorell, K., Muñoz-Ramírez, Z. Y., Wang, D., Sandoval-Motta, S., Boscolo Agostini, R et al. (2023). The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes. Nat Commun. 14(1), 8184. https://doi.org/10.1038/s41467-023-43562-y CR - [26] Herrero, R., Park, J. Y., Forman, D. (2014). The fight against gastric cancer–the IARC Working Group report. Best Pract. Res. Clin. Gastroenterol. 28(6), 1107-1114. https://doi.org/10.1016/j.bpg.2014.10.003 CR - [27] Safavi, M., Shams-Ardakani, M., Foroumadi, A. (2015). Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol.53(7), 939-960. https://doi.org/10.3109/13880209.2014.952837 CR - [28] Pichon, M., Pichard, B., Barrioz, T., Plouzeau, C., Croquet, V et al. (2020). Diagnostic accuracy of a noninvasive test for detection of Helicobacter pylori and resistance to clarithromycin in stool by the Amplidiag H. pylori+ ClariR real-time PCR assay. J Clin Microbiol. 58(4), 10.1128/jcm. 01787-01719. https://doi.org/10.1128/jcm.01787-19 CR - [29] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370 CR - [30] Garvey, E., Rhead, J., Suffian, S., Whiley, D., Mahmood, F et al. (2023). High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. J Med Microbiol. 72(11), 001776. https://doi.org/10.1099/jmm.0.001776 CR - [31] Poonyam, P., Chotivitayatarakorn, P., Vilaichone, R.-K. (2019). High effective of 14-day high-dose PPI-bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. APJCP, 20(9), 2859. https://doi.org/10.31557/APJCP.2019.20.9.2859 CR - [32] Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024). ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol, 119(9), 1730-1753. http://doi.org/10.14309/ajg.0000000000002968 CR - [33] Wu, P.-J., Tsay, F.-W., Wu, D.-C., Yang, J.-C., Chuah, S.-K., Chen, K.-Y., Sheu, M.-J. (2025). Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024. World J Gastroenterol, 31(39), 111380. http://doi.org/10.3748/wjg.v31.i39.111380 CR - [34] Zhou, X.-Z., Lyu, N.-H., Zhu, H.-Y., Cai, Q.-C., Kong, X.-Y., Xie, P., Du, Y.-Q. (2023). Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut, 72(5), 855-869. CR - [35] Silvan, J. M., Gutiérrez-Docio, A., Moreno-Fernandez, S., Alarcón-Cavero, T., Prodanov, M et al. (2020). Procyanidin-rich extract from grape seeds as a putative tool against Helicobacter pylori. Foods, 9(10), 1370. https://doi.org/10.3390/foods9101370 CR - [36] Nostro, A., Cellini, L., Bartolomeo, S. D., Cannatelli, M., Campli, E. D et al. (2006). Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20(3), 187-190. https://doi.org/10.1002/ptr.1830 CR - [37] Wang, Y.-C. (2014). Medicinal plant activity on Helicobacter pylori related diseases. WJG. 20(30), 10368. https://doi.org/10.3748/wjg.v20.i30.10368 CR - [38] Abou Baker, D. (2020). Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review. Biotechnol Rep. 26, e00470. https://doi.org/10.1016/j.btre.2020.e00470 CR - [39] Hajimahmoodi, M., Shams-Ardakani, M., Saniee, P., Siavoshi, F., Mehrabani, M et al. (2011). In vitro antibacterial activity of some Iranian medicinal plant extracts against Helicobacter pylori. Nat Prod Res. 25(11), 1059-1066. https://doi.org/10.1080/14786419.2010.501763 CR - [40] Nostro, A., Cellini, L., Bartolomeo, S. D., Campli, E. D., Grande, R et al. (2005). Antibacterial effect of plant extracts against Helicobacter pylori. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 19(3), 198-202. https://doi.org/10.1002/ptr.1640 CR - [41] Cogo, L. L., Monteiro, C. L. B., Miguel, M. D., Miguel, O. G., Cunico, M. M et al. (2010). Anti-Helicobacter pylori activity of plant extracts traditionally used for the treatment of gastrointestinal disorders. Braz J Microbiol. 41, 304-309. https://doi.org/10.1590/S1517-83822010000200007 CR - [42] Nariman, F., Eftekhar, F., Habibi, Z., Falsafi, T. (2004). Anti‐Helicobacter pylori activities of six Iranian plants. Helicobacter, 9(2), 146-151. https://doi.org/10.1111/j.1083-4389.2004.00211.x CR - [43] Ndip, R. N., Tarkang, A. E. M., Mbullah, S. M., Luma, H. N., Malongue, A et al. (2007). In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol. 114(3), 452-457. https://doi.org/10.1016/j.jep.2007.08.037 CR - [44] Yan, J., Peng, C., Chen, P., Zhang, W., Jiang, C et al. (2022). In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts. J Ethnopharmacol. 283, 114578. https://doi.org/10.1016/j.jep.2021.114578 CR - [45] Gao, T., Hou, M., Zhang, B., Pan, X., Liu, C., Sun, C., ... & Ma, A. (2021). Effects of cranberry beverages on oxidative stress and gut microbiota in subjects with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Food Funct. 12(15), 6878-6888. https://doi.org/10.1039/D1FO00467K CR - [46] Chen, S., Shen, W., Liu, Y., Dong, Q., & Shi, Y. (2023). Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial. Chin Med J, 136(14), 1690-1698. https://mednexus.org/doi/epdf/10.1097/CM9.0000000000002696 CR - [47] Edo, G. I., Obasohan, P., Makia, R. S., Abiola O, T., Umelo, E. C., Jikah, A. N., Umar, H. (2024). The use of quality control parameters in the evaluation of herbal drugs. A review. Discover Medicine, 1(1), 168. http://doi.org/10.1007/s44337-024-00177-6 CR - [48] Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., & Wang, C. (2023). Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol, 14, 1265178. http://doi.org/10.3389/fphar.2023.1265178 UR - https://doi.org/10.29002/asujse.1799861 L1 - https://dergipark.org.tr/en/download/article-file/5313797 ER -